Activated signal transducer and activator of transcription (STAT) 3: Localization in focal adhesions and function in ovarian cancer cell motility

Cancer Research

Volumn 64, Issue 10, 2004, Pages 3550-3558

  Silver, Debra L ^a,c   Naora, Honami ^b   Liu, Jinsong ^b   Cheng, Wenjun ^b   Montell, Denise J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; JANUS KINASE; PAXILLIN; STAT3 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL MOTILITY; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; FEMALE; FOCAL ADHESION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; HUMANS; MICE; NIH 3T3 CELLS; OVARIAN NEOPLASMS; PAXILLIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 2442663092     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3959     Document Type: Article

References (50)

1. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell 1999;98:295-303.
2. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002;8:945-54.
3. Levy DE, Darnell JE Jr. STATs: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-62.
4. Teglund S, McKay C, Schuetz E, et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998;93:841-50.
5. Takeda K, Noguchi K, Shi W, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997;94:3801-4.
6. Lacronique V, Boureux A, Valle V, et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 1997;278:1309-12.
7. Catlett-Falcone R, Landowski TH, Oshiro MM, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999;10:105-15.
8. Gao B, Shen X, Kunos G, et al. Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett 2001;488:179-84.
9. Yamashita S, Miyagi C, Carmany-Rampey A, et al. Stat3 controls cell movements during zebrafish gastrulation. Dev Cell 2002;2:363-75.
10. Sano S, Itami S, Takeda K, et al. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 1999; 18:4657-68.
11. Silver DL, Montell DJ. Paracrine signaling through the JAK/STAT pathway activates invasive behavior of ovarian epithelial cells in Drosophila. Cell 2001;107:831-41.
12. Scully R. Pathology of ovarian cancer precursors. J Cell Biochem Suppl 1995;23: 208-18.
13. Montell D. Border-cell migration: the race is on. Nat Rev Mol Cell Biol 2003;4:13-24.
14. Burke W, Jin X, Lin H, et al. Inhibition of constitutively active STAT3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001;20:7925-34.
15. Huang M, Page C, Reynolds RK, Lin J. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol 2000;79:67-73.
16. Savares T, Campbell C, McQuain C, et al. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas. Cytokine 2002;17:324-34.
17. Mora LB, Beuttner R, Seigne J, et al. Constitutive activation of STAT3 in human prostate tumors and cell lines: direct inhibition of STAT3 signaling induces apoptosis of prostate cancer cells. Cancer Res 2002;62:6659-66.
18. Geiger B, Bershadsky A, Pankov R, Yamada K. Transmembrane extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2001;2:793-805.
19. Ilic D, Furuta Y, Kanazawa S, et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995;377:539-44.
20. Hagel M, George EL, Kim A, et al. The adaptor protein Paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol Cell Biol 2002;22:901-15.
21. Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J 1999;18:2459-71.
22. Cary LA, Klinghoffer RA, Sachsenmaier C, Cooper JA. Src catalytic but not scaffolding function is needed for integrin-regulated tyrosine phosphorylation, cell migration, and cell spreading. Mol Cell Biol 2002;22:2427-40.
23. Xie B, Zhao J, Kitagawa M, et al. Focal adhesion kinase activates STAT1 in integrin-mediated cell migration and adhesion. J Biol Chem 2001;276:19512-23.
24. Zhang XF, Wang JF, Matczak E, Proper JA, Groopman JE. Janus kinase 2 is involved in stromal cell-derived factor-1α-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood 2001;97:3342-8.
25. Zhu T, Goh E, Lobie P. Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2. FAK is not required for STAT mediated transcription. J Biol Chem 1998;273:10682-9.
26. Turner C. Paxillin and focal adhesion signalling. Nat Cell Biol 2000;2:E231-6.
27. Garcia R, Bowman TL, Niu G, et al. Constitutive activation of STAT3 by src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001;20:2499-513.
28. Niu G, Bowman T, Huang M, et al. Roles of activated Src and STAT3 signaling in melanoma tumor cell growth. Oncogene 2002;21:7001-10.
29. Turkson J, Bowman T, Garcia R, Caldenhoven E, DeGroot R, Jove R. Stat3 activation by src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 1998;18:2545-52.
30. Laird AD, Li G, Moss KG, et al. Src family kinase activity is required for signal transducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and independent growth of human tumor cells. Mol Cancer Ther 2003;2:461-9.
31. Panetti T. Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and cell migration. Front Biosci 2002;7:d143-50.
32. Volberg T, Romer L, Zamir E, Geiger B. pp60c-src and related tyrosine kinases: a role in the assembly and reorganization of matrix adhesions. J Cell Sci 2001;114: 2279-89.
33. Bienz M, Clevers H. Armadillo/β-catenin signals in the nucleus-proof beyond a reasonable doubt? Nat Cell Biol 2003;5:179-82.
34. Nix D, Beckerle M. Nuclear-cytoplasmic shuttling of the focal contact, protein, zyxin: a potential mechanism for communication between sites of cell adhesion and nucleus. J Cell Biol 1997;138:1139-47.
35. Nix D, Fradelizi J, Bockhot S, et al. Targeting of zyxin to sites of actin membrane interaction and to the nucleus. J Biol Chem 2001;276:34759-67.
36. Wang Y, Gilmore T. Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear. Biochim Biophys Acta 2003;1593:115-20.
37. Balda MS, Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 2000;19:2024-33.
38. Bianchi E, Denti S, Granata A, et al. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 2000;404:617-21.
39. Hsueh Y, Wang TF, Yang F, Sheng M. Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2. Nature 2000; 404:241-2.
40. Beccari S, Teixeira L, Rorth P. The JAK/STAT pathway is required for border cell migration during Drosophila oogenesis. Mech Dev 2002;111:115-23.
41. Berger S, Siegert A, Denkert C, Kobel M, Hauptmann S. Interleukin-10 in serous ovarian carcinoma cell lines. Cancer Immunol Immunother 2001;50:328-33.
42. Kisseleva T, Bhattacharay S, Braunstein J, Schindler C. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 2002;285:1-24.
43. Watson J, Sensintaffar J, Berek J, Martinez-Maza O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990;50:6959-65.
44. Judson P, He X, Cance W, VanLe L. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 1999;86:1551-6.
45. Wiener J, Windham T, Estrella V, et al. Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. Gynecol Oncol 2003;88:73-9.
46. Irby RB, Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene 2000;19:5636-42.
47. Schlaepfer D, Mitra S. Multiple connections link FAK to cell motility and invasion. Curr Opin Genes Dev 2004;14:92-101.
48. Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M. Activation of signal transduction and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. J Urol 2002;168:762-5.
49. Wei D, Le X, Zheng L, et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 2003;22:319-29.
50. Kazansky A, Spencer D, Greenberg N. Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system. Cancer Res 2003;63:8757-62.